uploads///hypertension _

Taking Stock of Edwards Lifesciences’ Performance

By

Nov. 28 2018, Updated 12:12 p.m. ET

Edwards Lifesciences

A strong operational performance and steady uptick in Edwards Lifesciences’ (EW) stock price has kept investors interested in the stock in 2018. In this series, we’ll discuss Edwards Lifesciences’ financials, segmental performance, analysts’ views on the stock, and the company’s valuation metrics. Edwards Lifesciences is a leader in patient-focused solutions for structural heart disease and critical care monitoring.

Article continues below advertisement

Top line

Edwards Lifesciences generated total revenues of $906.6 million in the third quarter—compared to $821.5 million in the third quarter of 2017. The sales growth was driven by higher sales of the SAPIEN 3 transcatheter heart valve and the HemoSphere advanced monitoring platform. The company’s revenues from transcatheter heart valve therapy increased from $481.2 million in the third quarter of 2017 to $557.8 million in the third quarter.

The revenues from critical care increased from $144.7 million in the third quarter of 2017 to $164.2 million in the third quarter. The company’s revenues from surgical heart valve therapy decreased from $195.6 million in the third quarter of 2017 to $184.6 million in the third quarter.

For fiscal 2018 and 2019, Edwards Lifesciences is expected to generate revenues of $3.81 billion and $4.17 billion, respectively, compared to its revenues of $3.43 billion in fiscal 2017.

Abbott Laboratories (ABT), Align Technology (ALGN), and Boston Scientific’s (BSX) fiscal 2018 revenues are expected to be $30.66 billion, $1.95 billion, and $9.82 billion, respectively.

Next, we’ll discuss Edwards Lifesciences’ operational performance.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.